Loading
Thursday, October 22, 2026 · Vol. I, No. 43Independent · Canadian · Research-first
Before you compare Canadian research sourcesRun the free 10-point COA + batch audit at LynxLabs →
GHRP-6 · research summary
Regulatory toxicology and pharmacology : RTP · 2025. Summary drawn from the study's abstract. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.
Subchronic safety assessment in beagle dogs
“Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days..”
Beagle dogs
“Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days..”
28 consecutive days
“As general methodology, CIGB-500 was administered daily to dogs by intravenous route for 28 consecutive days.”
No adverse macroscopic or microscopic changes resulted from treatment
“Treatment with CIGB-500 did not result in any adverse macroscopic or microscopic changes.”
Source: PubMed 40024561 · DOI 10.1016/j.yrtph.2025.105798 · all study summaries